09:30
#1 DEVELOPMENT AND PSYCHOMETRIC EVALUATION OF THE ICIQ MODULES
Avery K1, Abrams P1, Chadwick M1, Donovan J2 1. Bristol Urological Institute, 2. University of Bristol
09:45
#2 A VALIDATED FEMALE PELVIC FLOOR QUESTIONNAIRE FOR CLINICIANS AND RESEARCHERS
Baessler K1, O'Neill S2, Maher C1, Battistutta D3 1. Royal Women's, Mater and Wesley Hospitals, 2. Royal Women's Hospital, 3. School of Public Health, QUT
10:00
#3 MEASURING PATIENT OUTCOMES IN OAB: THE OAB-q, ICIQ OAB-q SF AND SCREENER
Abrams P1, Avery K1, Zyczynski T2, Kopp Z2, Coyne K3 1. Bristol Urological Institute, 2. Pfizer, Inc., 3. MEDTAP International, Inc.
10:15
#4 Distribution of Pelvic Organ Prolapse (POP) in the general population; prevalence, severity, etiology and relation with the function of the pelvic floor muscles. Best Non-Clinical Abstract
Slieker-ten Hove M C P1, Vierhout M2, Bloembergen H3, Schoenmaker G4 1. Erasmus Medical Center, Department of Gynecology, 2. University Medical Center Nijmegen, 3. Erasmus Medical Center, Medical Faculty, 4. General Practitioners group Brielle, NL
10:30
#5 Natural history of the acquisition of night-time bladder control: tracking study to follow children from age 3 1/2 years living in Scotland
Morison M1, Staines H1, Sullivan F2, Wilson P3, Stone D3, Tappin D3, Henderson M1 1. University of Abertay Dundee, 2. University of Dundee, 3. University of Glasgow
10:45
#6 A genetic linkage study of detrusor overactivity
Morris A R1, Mullan G2, Roscioli T2, Buckley M F2, Moore K H1 1. Pelvic Floor Unit, St George Hospital, Sydney, 2. Department of Haematology and Genetics, Prince of Wales Hospital, Sydney